Nature Medicine

Ensuring remote diagnostics for pathologists: an open letter to the US Congress.  28:2453-2455. 2022

Temporal order of clinical and biomarker changes in familial frontotemporal dementia.  28:2194-2206. 2022

Genetic risk score enhances the risk prediction of severe obesity in adult survivors of childhood cancer.  28:1590-1598. 2022

Genome-wide polygenic score to predict chronic kidney disease across ancestries.  28:1412-1420. 2022

Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants (Nature Medicine, (2022), 28, 5, (1063-1071), 10.1038/s41591-022-01753-y).  28:1095. 2022

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants.  28:1063-1071. 2022

Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity.  28:766-779. 2022

Clinical trial design during and beyond the pandemic: the I-SPY COVID trial.  28:9-11. 2022

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial 2022

Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018.  27:1761-1782. 2021

Calming the cytokine storm in COVID-19.  27:1674-1675. 2021

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease.  27:1187-1196. 2021

Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial.  27:165-173. 2021

Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus.  26:1754-1765. 2020

Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/s41591-020-0807-6).  26:1308. 2020

Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.  26:750-759. 2020

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration.  26:387-397. 2020

Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis.  25:1772-1782. 2019

Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts.  25:911-919. 2019

Erratum to: Metformin reverses established lung fibrosis in a bleomycin model (Nature Medicine, (2018), 24, 8, (1121-1127), 10.1038/s41591-018-0087-6).  24:1627. 2018

Metformin reverses established lung fibrosis in a bleomycin model.  24:1121-1131. 2018

Verapamil and beta cell function in adults with recent-onset type 1 diabetes.  24:1108-1112. 2018

Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.  24:450-462. 2018

VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.  23:551-555. 2017

A chikungunya fever vaccine utilizing an insect-specific virus platform.  23:192-199. 2017

Impact of pre-Adapted HIV transmission.  22:606-613. 2016

A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.  22:421-426. 2016

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.  22:298-305. 2016

ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior.  21:1146-1153. 2015

Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis.  21:998-1009. 2015

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.  21:27-36. 2015

MicroRNA-124 modulates social behavior in frontotemporal dementia.  20:1381-1383. 2014

Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.  20:536-541. 2014

Thioredoxin-interacting protein regulates insulin transcription through microRNA-204.  19:1141-1146. 2013

Targeted estrogen delivery reverses the metabolic syndrome.  18:1847-1856. 2012

Heat from calcium cycling melts fat.  18:1458-1459. 2012

Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model.  18:1423-1428. 2012

Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.  18:1248-1253. 2012

Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.  18:595-599. 2012

Glutamate release by primary brain tumors induces epileptic activity.  17:1269-1274. 2011

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.  17:941-943. 2011

Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death.  17:692-699. 2011

Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity.  17:479-487. 2011

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.  16:793-798. 2010

T helper type 1 and 17 cells determine efficacy of interferon-Β in multiple sclerosis and experimental encephalomyelitis.  16:406-412. 2010

Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.  16:219-223. 2010

Gene copy number: Learning to count past two.  15:1127-1129. 2009

NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.  15:1077-1081. 2009

TGF-Β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation.  15:757-765. 2009

Will integrin inhibitors have proangiogenic effects in the clinic?.  15:726. 2009

SNO-hemoglobin and hypoxic vasodilation.  14:1009. 2008

SNO-hemoglobin and hypoxic vasodilation.  14:1009-1009. 2008

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.  14:931-938. 2008

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs.  14:762-766. 2008

SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation.  14:773-777. 2008

A MSC-ing link in metastasis?.  13:1289-1291. 2007

Fen1 mutations result in autoimmunity, chronic inflammation and cancers.  13:812-819. 2007

Phosphoinositides' link to neurodegeneration.  13:784-786. 2007

Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry.  12:972-977. 2006

Weathington et al. reply [2].  12:604. 2006

Induction of leptin resistance through direct interaction of C-reactive protein with leptin.  12:425-432. 2006

A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation.  12:317-323. 2006

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.  11:1170-1172. 2005

Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity.  10:927-934. 2004

Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.  9:1498-1505. 2003

T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation.  9:1318-1322. 2003

Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy.  8:1310-1317. 2002

Does neutrophil CD38 have a role in Ca⁺⁺ signaling triggered by β2 integrin?.  8:307-308. 2002

Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5⁺ cells.  8:150-156. 2002

Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo.  7:1209-1216. 2001

Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.  7:920-926. 2001

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.  7:954-960. 2001

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.  7:1320-1326. 2001

Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.  6:1140-1146. 2000

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.  6:76-81. 2000

Catalytic activity of antibodies against factor VIII in patients with hemophilia A..  5:1044-1047. 1999

Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen.  5:900-906. 1999

HIV-1 and HAART: A time to cure, a time to kill.  5:609-611. 1999

Tau gene mutation in familial progressive subcortical gliosis.  5:454-457. 1999

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.  4:1302-1307. 1998

An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow.  4:333-335. 1998

Gastrogenomic delights: A movable feast.  3:1076-1078. 1997

Allelic origin of the abnormal prion protein isoform in familial prion diseases.  3:1009-1015. 1997

Natural painkillers [1].  3:1302. 1997

Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line.  3:1280-1284. 1997

HIV viral load markers in clinical practice.  2:625-629. 1996

Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy.  2:649-654. 1996

Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations.  2:467-469. 1996

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.  2:347-350. 1996

Nonstop treatment of cystic fibrosis [2].  2:608-609. 1996

Tumor suppressor genes in the TGF-β signaling pathway? Loss of response to TGF-βs may be an important step in the development and progression of cancer. Recent studies show that receptors and proteins involved in TGF-β signaling may act as tumor suppressors.  2:390-391. 1996

Genetic origins of protein shape and interaction rules.  1:876-878. 1995

Reply to “…but not to protein folding?”.  1:1223. 1995

The molecular recognition theory applied to bispecific antibodies...but not to protein folding? [1].  1:1222-1223. 1995